BCL2 Inhibitors

BCL2 inhibitors are medications that work by targeting a specific protein called BCL2. Normally, our bodies have a natural way for cells to die when they are old or damaged; however, cancer cells often use the BCL2 protein to avoid this process. By blocking BCL2, these medications help cancer cells die as they naturally should, which can lead to a reduction of the disease in the blood and bone marrow. This topic provides information on how these drugs work, what to expect during your treatment, and ways to manage potential side effects.